Homocysteine: An independent risk factor for the failure of vascular intervention

British Journal of Surgery

Volumn 83, Issue 9, 1996, Pages 1238-1241

  Currie, I C ^a   Wilson, Y G ^a   Scott, J ^a   Day, A ^a   Stansbie, D ^a   Baird, R N ^a   Lamont, P M ^a   Tennant, W G ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; HOMOCYSTEINE;

AGE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; HEMODYNAMICS; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; VASCULAR SURGERY;

EID: 0029760366     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800830918     Document Type: Article

References (23)

1. Taylor LM Jr, DeFrang RD, Harris EJ Jr, Porter JM. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. J Vasc Surg 1991; 13: 128-36.
2. Molgaard J, Malinow MR, Lassvik C, Holm AC, Upson B, Olsson AG. Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication. J Intern Med 1992; 231: 273-9.
3. Clarke R, Daly L, Robinson K et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-55.
4. Malinow MR. Plasma homocyst(e)ine and arterial occlusive diseases: a mini-review. Clin Chem 1994; 41: 173-6.
5. Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. 6th ed. Vol 1. New York: McGraw-Hill, 1989: 693-734.
6. Dudman NPB, Wilcken DEL, Wang J, Lynch JF, Macey D, Lundberg P. Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb 1993; 13: 1253-60.
7. Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993; 57: 47-53.
8. Brattstrom L, Israelsson B, Norrving B et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis 1990; 81: 51-60.
9. 6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J Vascular Surgery 1994; 20: 933-40.
10. Valentine RJ. Premature peripheral atherosclerosis. Cardiovascular Surgery 1993; 1: 473-80.
11. McCully KS, Ragsdale BD. Production of arteriosclerosis by homocysteinemia. Am J Pathol 1970; 61: 2-11.
12. Harker LA, Slichter SJ, Scott CR, Ross R. Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med 1974; 291: 537-43.
13. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin Chem 1993; 39: 263-71.
14. Ueland PM, Refsum HH, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1993; 39: 1764-79.
15. Whitehead TP, Thorpe GHG, Maxwell SRJ. Enhanced chemiluminescent assay for antioxidant capacity in biological fluids. Analytica Chimica Acta 1992; 266: 265-77.
16. Stampfer MJ, Malinow MR, Willett WC et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 1992; 268: 877-81.
17. Boers GHJ, Smals AGH, Trijbels FJM et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985; 313: 709-15.
18. Aronson DC, Ruys T, van Bockel JH et al. A prospective survey of risk factors in young adults with arterial occlusive disease. Eur J Vasc Surg 1989; 3: 227-32.
19. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
20. Clowes AW, Reidy MA. Prevention of stenosis after vascular reconstruction: pharmacologic control of intimai hyperplasia - a review. J Vasc Surg 1991; 13: 885-92.
21. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986; 77: 1370-6.
22. Blom HJ, Engelen DPE, Boers GHJ et al. Lipid peroxidation in homocysteinaemia. J Inherit Metab Dis 1992; 15: 419-22.
23. Stamler JS, Osborne JA, Jaraki O et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993; 91: 308-18.